Noninvasive assessment of reperfusion and reocclusion after thrombolysis in acute myocardial infarction.
The clinical significance of ST-segment changes and of the time course of appearance in serum of different cardiac proteins has been reviewed for the diagnosis of coronary reperfusion and reocclusion after thrombolysis. In particular, the value of serial 12-lead electrocardiographic (ECG) studies, of Holter monitoring, and of continuous multilead computer-assisted ECG monitoring is compared. Regarding the serum proteins, the clinical significance of reperfusion indices described so far for serum creatine kinase (CK), its isoenzyme serum creatinine kinase MB, the CK isoforms, and myoglobin is reviewed. Emphasis is placed on (1) the calculation method used for deriving the reperfusion indices; (2) the sensitivity and the specificity of the reperfusion indices; (3) the minimum turn-around time needed to produce the reperfusion indices (depending on the practicability of the analytical and calculation methods and their applicability in an emergency laboratory); (4) the ability of the indices to produce reliable estimates of reperfusion efficacy of the thrombolytic agents under study; and (5) the ability of the marker proteins to detect reinfarction as well as the suitability of the markers to detect real-time necrosis.
Klootwijk
P
P
Thoraxcenter, Erasmus University, Rotterdam, The Netherlands.
Cobbaert
C
C
Fioretti
P
P
Kint
P P
PP
Simoons
M L
ML
D003326:Coronary Circulation; D003402:Creatine Kinase / Q000097:blood; D004562:Electrocardiography; D006801:Humans; D007527:Isoenzymes; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D009211:Myoglobin / Q000097:blood; D012008:Recurrence; D012680:Sensitivity and Specificity; D015912:Thrombolytic Therapy
D007527:Isoenzymes; D009211:Myoglobin; D003402:Creatine Kinase